Intravenous Methylprednisolone Versus Therapeutic Plasma Exchange for Treatment of Anti-N-Methyl-D-Aspartate Receptor Antibody Encephalitis: A Retrospective Review
Intravenous Methylprednisolone Versus Therapeutic Plasma Exchange for Treatment of Anti-N-Methyl-D-Aspartate Receptor Antibody Encephalitis: A Retrospective Review
复制标题
DOI:
10.1002/jca.21363
复制
发表时间:
2015-08-01
影响因子:
1.5
通讯作者:
Graves, Donna
中科院分区:
文献类型:
--
作者:
DeSena, Allen D.;Noland, Daniel K.;Graves, Donna
Introduction: Anti-N-methyl-d-aspartate (NMDA) receptor antibody encephalitis is an increasingly recognized form of autoimmune encephalitis. Conventional treatments include therapies such as corticosteroids, intravenous immunoglobulin (IVIg), and/or therapeutic plasma exchange (TPE). Although TPE is regularly used for treatment of anti-NMDA receptor antibody encephalitis, the American Society for Apheresis has given it a category III recommendation only. Earlier administered immunotherapies in tumor-negative patients may facilitate faster recoveries, but it remains unclear whether or not TPE is superior to steroids and/or IVIG. Methods: We retrospectively evaluated 10 of 14 patients that received steroids and TPE with modified Rankin scores and subjectively assessed the point of largest sustained improvement in all 14 patients. Results: In the patients that received both steroids and TPE at our institution during the same hospitalization (only 10 of 14 patients), 7/10 patients after TPE had improved with the modified Rankin score versus 3/10 patients after steroids. The average modified Rankin score improvement after steroids in this group was -0.1 as compared with 0.4 after TPE. Based on subjective chart review analysis during which all 14 patients were assessed, the largest sustained improvement occurred immediately following the third-fifth exchange in 9/14 patients, whereas only 2/14 patients appeared to have had significant benefit immediately following steroids. Conclusions: This is compelling preliminary data that suggests that corticosteroids may not be as effective compared to steroids followed by TPE. Given the importance of time-sensitive treatment, more formal studies may illuminate the ideal first-line treatment for anti-NMDA receptor antibody encephalitis. J. Clin. Apheresis 30:212-216, 2015. (c) 2015 Wiley Periodicals, Inc.